Core Laboratories/$CLB
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Core Laboratories
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
Ticker
$CLB
Sector
Primary listing
NYSE
Industry
Energy Equipment & Services
Headquarters
Employees
3,400
ISIN
US21867A1051
Website
CLB Metrics
BasicAdvanced
$605M
21.88
$0.59
2.00
$0.04
0.31%
Price and volume
Market cap
$605M
Beta
2
52-week high
$25.13
52-week low
$10.14
Average daily volume
525K
Dividend rate
$0.04
Financial strength
Current ratio
2.205
Quick ratio
1.341
Long term debt to equity
64.91
Total debt to equity
69.403
Dividend payout ratio (TTM)
6.70%
Interest coverage (TTM)
4.33%
Profitability
EBITDA (TTM)
64.834
Gross margin (TTM)
19.77%
Net profit margin (TTM)
5.41%
Operating margin (TTM)
9.66%
Effective tax rate (TTM)
32.95%
Revenue per employee (TTM)
$150,000
Management effectiveness
Return on assets (TTM)
5.08%
Return on equity (TTM)
11.57%
Valuation
Price to earnings (TTM)
21.879
Price to revenue (TTM)
1.168
Price to book
2.38
Price to tangible book (TTM)
11.59
Price to free cash flow (TTM)
13.747
Free cash flow yield (TTM)
7.27%
Free cash flow per share (TTM)
93.84%
Dividend yield (TTM)
0.31%
Forward dividend yield
0.31%
Growth
Revenue change (TTM)
1.32%
Earnings per share change (TTM)
-25.31%
3-year revenue growth (CAGR)
2.76%
10-year revenue growth (CAGR)
-6.70%
3-year earnings per share growth (CAGR)
42.73%
10-year earnings per share growth (CAGR)
-19.49%
10-year dividend per share growth (CAGR)
-32.54%
What the Analysts think about CLB
Analyst ratings (Buy, Hold, Sell) for Core Laboratories stock.
Bulls say / Bears say
Core Laboratories' Reservoir Description segment reported a 3% sequential revenue increase in Q3 2024, indicating growing demand for reservoir rock and fluid analysis services. (wfla.com)
The company secured multiple contracts for Carbon Capture and Sequestration projects in the Gulf Coast region, leveraging its expertise in reservoir characterization to expand into the growing CCS market. (wfla.com)
Core Laboratories' engagement in Middle Eastern projects expanded, with Kuwait Oil Company selecting the firm for a comprehensive fluid analysis campaign, highlighting its strong position in international markets. (wfla.com)
The Bank of New York Mellon Corp reduced its holdings in Core Laboratories by 5.9% in Q4 2024, potentially signaling decreased confidence from institutional investors. (marketbeat.com)
Zacks Research lowered its Q2 2025 earnings per share estimate for Core Laboratories from $0.25 to $0.21, reflecting a more pessimistic outlook on the company's near-term financial performance. (marketbeat.com)
Core Laboratories' Q4 2024 revenue declined by 4% sequentially, primarily due to decreased U.S. onshore activity and geopolitical conflicts affecting laboratory services, indicating potential challenges in maintaining revenue growth. (insidermonkey.com)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.
CLB Financial Performance
Revenues and expenses
CLB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Core Laboratories stock?
Core Laboratories (CLB) has a market cap of $605M as of July 04, 2025.
What is the P/E ratio for Core Laboratories stock?
The price to earnings (P/E) ratio for Core Laboratories (CLB) stock is 21.88 as of July 04, 2025.
Does Core Laboratories stock pay dividends?
Yes, the Core Laboratories (CLB) stock pays dividends to shareholders. As of July 04, 2025, the dividend rate is $0.04 and the yield is 0.31%. Core Laboratories has a payout ratio of 6.7% on a trailing twelve-month basis.
When is the next Core Laboratories dividend payment date?
The next Core Laboratories (CLB) dividend payment date is unconfirmed.
What is the beta indicator for Core Laboratories?
Core Laboratories (CLB) has a beta rating of 2. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.